Memorial Sloan-Kettering Cancer Center, New York, NY
Paul A. Glare , Mary K. Plakovic , Anna Schloms , Barbara Egan , Leonard Saltz , David Paul Kelsen
Screened patients | Team A (n=113) | Team B (n=116) | p value |
---|---|---|---|
Status on admission | |||
Time since diagnosis (months) | 13 | 15 | n.s. |
Advanced disease | 92% | 97% | n.s. |
Best supportive care | 36% | 39% | n.s. |
Died within next 3 months | 33% | 45% | n.s. |
Pain score ≥ 7/10 | 33% | 34% | n.s. |
Screen positive | 71% | 56% | 0.028 |
Outcomes | |||
Consults | 42% | 15% | <0.0001 |
Pain score ≥ 7/10, day 4* | 13% | 38% | n.s |
Median length of stay (days) | 4 | 4 | n.s. |
Died in hospital | 4% | 7% | n.s. |
Hospice referral | 19% | 21% | n.s. |
≤3 days on hospice | 1% | 3% | n.s. |
*incomplete data
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2023 ASCO Annual Meeting
First Author: Christine Ann Garcia
2023 ASCO Quality Care Symposium
First Author: Marvin Omar Delgado-Guay
2022 ASCO Quality Care Symposium
First Author: Megan C. Edmonds
2022 ASCO Annual Meeting
First Author: Ajeet Gajra